Clinical Trial Detail

NCT ID NCT01344824
Title Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Who Are Light or Never Smokers
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab

Erlotinib

Carboplatin

Pemetrexed Disodium

Age Groups: senior adult

No variant requirements are available.